1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Infantile Spasms Therapeutics Market Size Growth Rate by Type: 2017 VS 2021 VS 2028 1.2.2 Oral 1.2.3 Injection 1.3 Market by Application 1.3.1 Global Infantile Spasms Therapeutics Market Share by Application: 2017 VS 2021 VS 2028 1.3.2 Hospital 1.3.3 Clinic 1.3.4 Other 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Infantile Spasms Therapeutics Market Perspective (2017-2028) 2.2 Infantile Spasms Therapeutics Growth Trends by Region 2.2.1 Infantile Spasms Therapeutics Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Infantile Spasms Therapeutics Historic Market Size by Region (2017-2022) 2.2.3 Infantile Spasms Therapeutics Forecasted Market Size by Region (2023-2028) 2.3 Infantile Spasms Therapeutics Market Dynamics 2.3.1 Infantile Spasms Therapeutics Industry Trends 2.3.2 Infantile Spasms Therapeutics Market Drivers 2.3.3 Infantile Spasms Therapeutics Market Challenges 2.3.4 Infantile Spasms Therapeutics Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Infantile Spasms Therapeutics Players by Revenue 3.1.1 Global Top Infantile Spasms Therapeutics Players by Revenue (2017-2022) 3.1.2 Global Infantile Spasms Therapeutics Revenue Market Share by Players (2017-2022) 3.2 Global Infantile Spasms Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Infantile Spasms Therapeutics Revenue 3.4 Global Infantile Spasms Therapeutics Market Concentration Ratio 3.4.1 Global Infantile Spasms Therapeutics Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Infantile Spasms Therapeutics Revenue in 2021 3.5 Infantile Spasms Therapeutics Key Players Head office and Area Served 3.6 Key Players Infantile Spasms Therapeutics Product Solution and Service 3.7 Date of Enter into Infantile Spasms Therapeutics Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Infantile Spasms Therapeutics Breakdown Data by Type 4.1 Global Infantile Spasms Therapeutics Historic Market Size by Type (2017-2022) 4.2 Global Infantile Spasms Therapeutics Forecasted Market Size by Type (2023-2028) 5 Infantile Spasms Therapeutics Breakdown Data by Application 5.1 Global Infantile Spasms Therapeutics Historic Market Size by Application (2017-2022) 5.2 Global Infantile Spasms Therapeutics Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Infantile Spasms Therapeutics Market Size (2017-2028) 6.2 North America Infantile Spasms Therapeutics Market Size by Country (2017-2022) 6.3 North America Infantile Spasms Therapeutics Market Size by Country (2023-2028) 6.4 United States 6.5 Canada 7 Europe 7.1 Europe Infantile Spasms Therapeutics Market Size (2017-2028) 7.2 Europe Infantile Spasms Therapeutics Market Size by Country (2017-2022) 7.3 Europe Infantile Spasms Therapeutics Market Size by Country (2023-2028) 7.4 Germany 7.5 France 7.6 U.K. 7.7 Italy 7.8 Russia 7.9 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Infantile Spasms Therapeutics Market Size (2017-2028) 8.2 Asia-Pacific Infantile Spasms Therapeutics Market Size by Country (2017-2022) 8.3 Asia-Pacific Infantile Spasms Therapeutics Market Size by Country (2023-2028) 8.4 China 8.5 Japan 8.6 South Korea 8.7 Southeast Asia 8.8 India 8.9 Australia 9 Latin America 9.1 Latin America Infantile Spasms Therapeutics Market Size (2017-2028) 9.2 Latin America Infantile Spasms Therapeutics Market Size by Country (2017-2022) 9.3 Latin America Infantile Spasms Therapeutics Market Size by Country (2023-2028) 9.4 Mexico 9.5 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Infantile Spasms Therapeutics Market Size (2017-2028) 10.2 Middle East & Africa Infantile Spasms Therapeutics Market Size by Country (2017-2022) 10.3 Middle East & Africa Infantile Spasms Therapeutics Market Size by Country (2023-2028) 10.4 Turkey 10.5 Saudi Arabia 10.6 UAE 11 Key Players Profiles 11.1 Mallinckrodt 11.1.1 Mallinckrodt Company Detail 11.1.2 Mallinckrodt Business Overview 11.1.3 Mallinckrodt Infantile Spasms Therapeutics Introduction 11.1.4 Mallinckrodt Revenue in Infantile Spasms Therapeutics Business (2017-2022) 11.1.5 Mallinckrodt Recent Development 11.2 H. Lundbeck 11.2.1 H. Lundbeck Company Detail 11.2.2 H. Lundbeck Business Overview 11.2.3 H. Lundbeck Infantile Spasms Therapeutics Introduction 11.2.4 H. Lundbeck Revenue in Infantile Spasms Therapeutics Business (2017-2022) 11.2.5 H. Lundbeck Recent Development 11.3 Insys Therapeutics 11.3.1 Insys Therapeutics Company Detail 11.3.2 Insys Therapeutics Business Overview 11.3.3 Insys Therapeutics Infantile Spasms Therapeutics Introduction 11.3.4 Insys Therapeutics Revenue in Infantile Spasms Therapeutics Business (2017-2022) 11.3.5 Insys Therapeutics Recent Development 11.4 Orphelia Pharma 11.4.1 Orphelia Pharma Company Detail 11.4.2 Orphelia Pharma Business Overview 11.4.3 Orphelia Pharma Infantile Spasms Therapeutics Introduction 11.4.4 Orphelia Pharma Revenue in Infantile Spasms Therapeutics Business (2017-2022) 11.4.5 Orphelia Pharma Recent Development 11.5 Valerion Therapeutics 11.5.1 Valerion Therapeutics Company Detail 11.5.2 Valerion Therapeutics Business Overview 11.5.3 Valerion Therapeutics Infantile Spasms Therapeutics Introduction 11.5.4 Valerion Therapeutics Revenue in Infantile Spasms Therapeutics Business (2017-2022) 11.5.5 Valerion Therapeutics Recent Development 11.6 Catalyst Pharmaceuticals 11.6.1 Catalyst Pharmaceuticals Company Detail 11.6.2 Catalyst Pharmaceuticals Business Overview 11.6.3 Catalyst Pharmaceuticals Infantile Spasms Therapeutics Introduction 11.6.4 Catalyst Pharmaceuticals Revenue in Infantile Spasms Therapeutics Business (2017-2022) 11.6.5 Catalyst Pharmaceuticals Recent Development 11.7 Anavex Life Sciences 11.7.1 Anavex Life Sciences Company Detail 11.7.2 Anavex Life Sciences Business Overview 11.7.3 Anavex Life Sciences Infantile Spasms Therapeutics Introduction 11.7.4 Anavex Life Sciences Revenue in Infantile Spasms Therapeutics Business (2017-2022) 11.7.5 Anavex Life Sciences Recent Development 11.8 Retrophin 11.8.1 Retrophin Company Detail 11.8.2 Retrophin Business Overview 11.8.3 Retrophin Infantile Spasms Therapeutics Introduction 11.8.4 Retrophin Revenue in Infantile Spasms Therapeutics Business (2017-2022) 11.8.5 Retrophin Recent Development 11.9 GW Pharmaceuticals 11.9.1 GW Pharmaceuticals Company Detail 11.9.2 GW Pharmaceuticals Business Overview 11.9.3 GW Pharmaceuticals Infantile Spasms Therapeutics Introduction 11.9.4 GW Pharmaceuticals Revenue in Infantile Spasms Therapeutics Business (2017-2022) 11.9.5 GW Pharmaceuticals Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Infantile Spasms Therapeutics Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028 Table 2. Key Players of Oral Table 3. Key Players of Injection Table 4. Global Infantile Spasms Therapeutics Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028 Table 5. Global Infantile Spasms Therapeutics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 6. Global Infantile Spasms Therapeutics Market Size by Region (2017-2022) & (US$ Million) Table 7. Global Infantile Spasms Therapeutics Market Share by Region (2017-2022) Table 8. Global Infantile Spasms Therapeutics Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 9. Global Infantile Spasms Therapeutics Market Share by Region (2023-2028) Table 10. Infantile Spasms Therapeutics Market Trends Table 11. Infantile Spasms Therapeutics Market Drivers Table 12. Infantile Spasms Therapeutics Market Challenges Table 13. Infantile Spasms Therapeutics Market Restraints Table 14. Global Infantile Spasms Therapeutics Revenue by Players (2017-2022) & (US$ Million) Table 15. Global Infantile Spasms Therapeutics Market Share by Players (2017-2022) Table 16. Global Top Infantile Spasms Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infantile Spasms Therapeutics as of 2021) Table 17. Ranking of Global Top Infantile Spasms Therapeutics Companies by Revenue (US$ Million) in 2021 Table 18. Global 5 Largest Players Market Share by Infantile Spasms Therapeutics Revenue (CR5 and HHI) & (2017-2022) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Infantile Spasms Therapeutics Product Solution and Service Table 21. Date of Enter into Infantile Spasms Therapeutics Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Infantile Spasms Therapeutics Market Size by Type (2017-2022) & (US$ Million) Table 24. Global Infantile Spasms Therapeutics Revenue Market Share by Type (2017-2022) Table 25. Global Infantile Spasms Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 26. Global Infantile Spasms Therapeutics Revenue Market Share by Type (2023-2028) Table 27. Global Infantile Spasms Therapeutics Market Size by Application (2017-2022) & (US$ Million) Table 28. Global Infantile Spasms Therapeutics Revenue Market Share by Application (2017-2022) Table 29. Global Infantile Spasms Therapeutics Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 30. Global Infantile Spasms Therapeutics Revenue Market Share by Application (2023-2028) Table 31. North America Infantile Spasms Therapeutics Market Size by Country (2017-2022) & (US$ Million) Table 32. North America Infantile Spasms Therapeutics Market Size by Country (2023-2028) & (US$ Million) Table 33. Europe Infantile Spasms Therapeutics Market Size by Country (2017-2022) & (US$ Million) Table 34. Europe Infantile Spasms Therapeutics Market Size by Country (2023-2028) & (US$ Million) Table 35. Asia-Pacific Infantile Spasms Therapeutics Market Size by Region (2017-2022) & (US$ Million) Table 36. Asia-Pacific Infantile Spasms Therapeutics Market Size by Region (2023-2028) & (US$ Million) Table 37. Latin America Infantile Spasms Therapeutics Market Size by Country (2017-2022) & (US$ Million) Table 38. Latin America Infantile Spasms Therapeutics Market Size by Country (2023-2028) & (US$ Million) Table 39. Middle East & Africa Infantile Spasms Therapeutics Market Size by Country (2017-2022) & (US$ Million) Table 40. Middle East & Africa Infantile Spasms Therapeutics Market Size by Country (2023-2028) & (US$ Million) Table 41. Mallinckrodt Company Detail Table 42. Mallinckrodt Business Overview Table 43. Mallinckrodt Infantile Spasms Therapeutics Product Table 44. Mallinckrodt Revenue in Infantile Spasms Therapeutics Business (2017-2022) & (US$ Million) Table 45. Mallinckrodt Recent Development Table 46. H. Lundbeck Company Detail Table 47. H. Lundbeck Business Overview Table 48. H. Lundbeck Infantile Spasms Therapeutics Product Table 49. H. Lundbeck Revenue in Infantile Spasms Therapeutics Business (2017-2022) & (US$ Million) Table 50. H. Lundbeck Recent Development Table 51. Insys Therapeutics Company Detail Table 52. Insys Therapeutics Business Overview Table 53. Insys Therapeutics Infantile Spasms Therapeutics Product Table 54. Insys Therapeutics Revenue in Infantile Spasms Therapeutics Business (2017-2022) & (US$ Million) Table 55. Insys Therapeutics Recent Development Table 56. Orphelia Pharma Company Detail Table 57. Orphelia Pharma Business Overview Table 58. Orphelia Pharma Infantile Spasms Therapeutics Product Table 59. Orphelia Pharma Revenue in Infantile Spasms Therapeutics Business (2017-2022) & (US$ Million) Table 60. Orphelia Pharma Recent Development Table 61. Valerion Therapeutics Company Detail Table 62. Valerion Therapeutics Business Overview Table 63. Valerion Therapeutics Infantile Spasms Therapeutics Product Table 64. Valerion Therapeutics Revenue in Infantile Spasms Therapeutics Business (2017-2022) & (US$ Million) Table 65. Valerion Therapeutics Recent Development Table 66. Catalyst Pharmaceuticals Company Detail Table 67. Catalyst Pharmaceuticals Business Overview Table 68. Catalyst Pharmaceuticals Infantile Spasms Therapeutics Product Table 69. Catalyst Pharmaceuticals Revenue in Infantile Spasms Therapeutics Business (2017-2022) & (US$ Million) Table 70. Catalyst Pharmaceuticals Recent Development Table 71. Anavex Life Sciences Company Detail Table 72. Anavex Life Sciences Business Overview Table 73. Anavex Life Sciences Infantile Spasms Therapeutics Product Table 74. Anavex Life Sciences Revenue in Infantile Spasms Therapeutics Business (2017-2022) & (US$ Million) Table 75. Anavex Life Sciences Recent Development Table 76. Retrophin Company Detail Table 77. Retrophin Business Overview Table 78. Retrophin Infantile Spasms Therapeutics Product Table 79. Retrophin Revenue in Infantile Spasms Therapeutics Business (2017-2022) & (US$ Million) Table 80. Retrophin Recent Development Table 81. GW Pharmaceuticals Company Detail Table 82. GW Pharmaceuticals Business Overview Table 83. GW Pharmaceuticals Infantile Spasms Therapeutics Product Table 84. GW Pharmaceuticals Revenue in Infantile Spasms Therapeutics Business (2017-2022) & (US$ Million) Table 85. GW Pharmaceuticals Recent Development Table 86. Research Programs/Design for This Report Table 87. Key Data Information from Secondary Sources Table 88. Key Data Information from Primary Sources List of Figures Figure 1. Global Infantile Spasms Therapeutics Market Share by Type: 2021 VS 2028 Figure 2. Oral Features Figure 3. Injection Features Figure 4. Global Infantile Spasms Therapeutics Market Share by Application in 2021 & 2028 Figure 5. Hospital Case Studies Figure 6. Clinic Case Studies Figure 7. Other Case Studies Figure 8. Infantile Spasms Therapeutics Report Years Considered Figure 9. Global Infantile Spasms Therapeutics Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 10. Global Infantile Spasms Therapeutics Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 11. Global Infantile Spasms Therapeutics Market Share by Region: 2021 VS 2028 Figure 12. Global Infantile Spasms Therapeutics Market Share by Players in 2021 Figure 13. Global Top Infantile Spasms Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infantile Spasms Therapeutics as of 2021) Figure 14. The Top 10 and 5 Players Market Share by Infantile Spasms Therapeutics Revenue in 2021 Figure 15. North America Infantile Spasms Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 16. North America Infantile Spasms Therapeutics Market Share by Country (2017-2028) Figure 17. United States Infantile Spasms Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 18. Canada Infantile Spasms Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 19. Europe Infantile Spasms Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 20. Europe Infantile Spasms Therapeutics Market Share by Country (2017-2028) Figure 21. Germany Infantile Spasms Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 22. France Infantile Spasms Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 23. U.K. Infantile Spasms Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 24. Italy Infantile Spasms Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 25. Russia Infantile Spasms Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 26. Nordic Countries Infantile Spasms Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 27. Asia-Pacific Infantile Spasms Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. Asia-Pacific Infantile Spasms Therapeutics Market Share by Region (2017-2028) Figure 29. China Infantile Spasms Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. Japan Infantile Spasms Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 31. South Korea Infantile Spasms Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 32. Southeast Asia Infantile Spasms Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. India Infantile Spasms Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 34. Australia Infantile Spasms Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 35. Latin America Infantile Spasms Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 36. Latin America Infantile Spasms Therapeutics Market Share by Country (2017-2028) Figure 37. Mexico Infantile Spasms Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 38. Brazil Infantile Spasms Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. Middle East & Africa Infantile Spasms Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 40. Middle East & Africa Infantile Spasms Therapeutics Market Share by Country (2017-2028) Figure 41. Turkey Infantile Spasms Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 42. Saudi Arabia Infantile Spasms Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 43. Mallinckrodt Revenue Growth Rate in Infantile Spasms Therapeutics Business (2017-2022) Figure 44. H. Lundbeck Revenue Growth Rate in Infantile Spasms Therapeutics Business (2017-2022) Figure 45. Insys Therapeutics Revenue Growth Rate in Infantile Spasms Therapeutics Business (2017-2022) Figure 46. Orphelia Pharma Revenue Growth Rate in Infantile Spasms Therapeutics Business (2017-2022) Figure 47. Valerion Therapeutics Revenue Growth Rate in Infantile Spasms Therapeutics Business (2017-2022) Figure 48. Catalyst Pharmaceuticals Revenue Growth Rate in Infantile Spasms Therapeutics Business (2017-2022) Figure 49. Anavex Life Sciences Revenue Growth Rate in Infantile Spasms Therapeutics Business (2017-2022) Figure 50. Retrophin Revenue Growth Rate in Infantile Spasms Therapeutics Business (2017-2022) Figure 51. GW Pharmaceuticals Revenue Growth Rate in Infantile Spasms Therapeutics Business (2017-2022) Figure 52. Bottom-up and Top-down Approaches for This Report Figure 53. Data Triangulation Figure 54. Key Executives Interviewed

Mallinckrodt H. Lundbeck Insys Therapeutics Orphelia Pharma Valerion Therapeutics Catalyst Pharmaceuticals Anavex Life Sciences Retrophin GW Pharmaceuticals